Literature DB >> 33466686

Experimental and Computational Observations of Immunogenic Cobalt Porphyrin Lipid Bilayers: Nanodomain-Enhanced Antigen Association.

Jasmin Federizon1, Conrard Giresse Tetsassi Feugmo2, Wei-Chiao Huang1, Xuedan He1, Kazutoyo Miura3, Aida Razi4, Joaquin Ortega4, Mikko Karttunen2,5,6, Jonathan F Lovell1.   

Abstract

Cobalt porphyrin phospholipid (CoPoP) can incorporate within bilayers to enable non-covalent surface-display of antigens on liposomes by mixing with proteins bearing a polyhistidine tag (his-tag); however, the mechanisms for how this occurs are poorly understood. These were investigated using the his-tagged model antigen Pfs25, a protein antigen candidate for malaria transmission-blocking vaccines. Pfs25 was found to associate with the small molecule aquocobalamin, a form of vitamin B12 and a cobalt-containing corrin macrocycle, but without particle formation, enabling comparative assessment. Relative to CoPoP liposomes, binding and serum stability studies indicated a weaker association of Pfs25 to aquocobalamin or cobalt nitrilotriacetic acid (Co-NTA) liposomes, which have cobalt displayed in the aqueous phase on lipid headgroups. Antigen internalization by macrophages was enhanced with Pfs25 bound to CoPoP liposomes. Immunization in mice with Pfs25 bound to CoPoP liposomes elicited antibodies that recognized ookinetes and showed transmission-reducing activity. To explore the physical mechanisms involved, we employed molecular dynamics (MD) simulations of bilayers containing phospholipid, cholesterol, as well as either CoPoP or NTA-functionalized lipids. The results show that the CoPoP-containing bilayer creates nanodomains that allow access for a limited but sufficient amount of water molecules that could be replaced by his-tags due to their favorable free energy properties allowing for stabilization. The position of the metal center within the NTA liposomes was much more exposed to the aqueous environment, which could explain its limited capacity for stabilizing Pfs25. This study illustrates the impact of CoPoP-induced antigen particleization in enhancing vaccine efficacy, and provides molecular insights into the CoPoP bilayer properties that enable this.

Entities:  

Keywords:  antigens; bilayers; malaria; molecular dynamics; particles; simulations; vaccines

Year:  2021        PMID: 33466686      PMCID: PMC7828809          DOI: 10.3390/pharmaceutics13010098

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  50 in total

1.  P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation.

Authors:  Berk Hess
Journal:  J Chem Theory Comput       Date:  2008-01       Impact factor: 6.006

2.  MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy.

Authors:  Shawn Q Zheng; Eugene Palovcak; Jean-Paul Armache; Kliment A Verba; Yifan Cheng; David A Agard
Journal:  Nat Methods       Date:  2017-02-27       Impact factor: 28.547

3.  Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles.

Authors:  Rajesh Kumar; Paresh C Ray; Dibyadyuti Datta; Geetha P Bansal; Evelina Angov; Nirbhay Kumar
Journal:  Vaccine       Date:  2015-08-20       Impact factor: 3.641

4.  Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions.

Authors:  Shuai Shao; Venugopal Rajendiran; Jonathan F Lovell
Journal:  Coord Chem Rev       Date:  2017-09-22       Impact factor: 22.315

5.  Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.

Authors:  Jasmin Federizon; Amber Frye; Wei-Chiao Huang; Thomas M Hart; Xuedan He; Christopher Beltran; Ashley L Marcinkiewicz; Iain L Mainprize; Melanie K B Wills; Yi-Pin Lin; Jonathan F Lovell
Journal:  Vaccine       Date:  2019-11-11       Impact factor: 3.641

Review 6.  Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.

Authors:  Moses O Oyewumi; Amit Kumar; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

7.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

Authors:  A N Vermeulen; T Ponnudurai; P J Beckers; J P Verhave; M A Smits; J H Meuwissen
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

Review 8.  Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.

Authors:  Signe Tandrup Schmidt; Camilla Foged; Karen Smith Korsholm; Thomas Rades; Dennis Christensen
Journal:  Pharmaceutics       Date:  2016-03-10       Impact factor: 6.321

9.  Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.

Authors:  Yuanyuan Li; Darren B Leneghan; Kazutoyo Miura; Daria Nikolaeva; Iona J Brian; Matthew D J Dicks; Alex J Fyfe; Sarah E Zakutansky; Simone de Cassan; Carole A Long; Simon J Draper; Adrian V S Hill; Fergal Hill; Sumi Biswas
Journal:  Sci Rep       Date:  2016-01-08       Impact factor: 4.379

10.  A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.

Authors:  Wei-Chiao Huang; Bingbing Deng; Cuiyan Lin; Kevin A Carter; Jumin Geng; Aida Razi; Xuedan He; Upendra Chitgupi; Jasmin Federizon; Boyang Sun; Carole A Long; Joaquin Ortega; Sheetij Dutta; C Richter King; Kazutoyo Miura; Shwu-Maan Lee; Jonathan F Lovell
Journal:  Nat Nanotechnol       Date:  2018-10-08       Impact factor: 39.213

View more
  5 in total

1.  A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challenge.

Authors:  Zachary R Sia; Xuedan He; Ali Zhang; Jann C Ang; Shuai Shao; Amal Seffouh; Wei-Chiao Huang; Michael R D'Agostino; Amir Teimouri Dereshgi; Sambhara Suryaprakash; Joaquin Ortega; Hanne Andersen; Matthew S Miller; Bruce A Davidson; Jonathan F Lovell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 2.  Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials.

Authors:  Citlaly Gutiérrez Rodelo; Rafael A Salinas; Erika Armenta JaimeArmenta; Silvia Armenta; Andrés Galdámez-Martínez; Silvia E Castillo-Blum; Horacio Astudillo-de la Vega; Andrews Nirmala Grace; Carlos A Aguilar-Salinas; Juliana Gutiérrez Rodelo; Graham Christie; Walaa F Alsanie; Guillermo Santana; Vijay Kumar Thakur; Ateet Dutt
Journal:  Coord Chem Rev       Date:  2022-01-25       Impact factor: 22.315

Review 3.  Virus-like particles against infectious disease and cancer: guidance for the nano-architect.

Authors:  Rory A Hills; Mark Howarth
Journal:  Curr Opin Biotechnol       Date:  2021-10-29       Impact factor: 9.740

4.  Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages.

Authors:  Wei-Chiao Huang; Moustafa T Mabrouk; Luwen Zhou; Minami Baba; Mayumi Tachibana; Motomi Torii; Eizo Takashima; Emily Locke; Jordan Plieskatt; C Richter King; Camila H Coelho; Patrick E Duffy; Carole Long; Takafumi Tsuboi; Kazutoyo Miura; Yimin Wu; Tomoko Ishino; Jonathan F Lovell
Journal:  Commun Biol       Date:  2022-08-01

Review 5.  Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks.

Authors:  Seth-Frerich Fobian; Ziyun Cheng; Timo L M Ten Hagen
Journal:  Pharmaceutics       Date:  2021-12-23       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.